When levels of black carbon, or soot, in the air are high, walking outside can worsen cough and increase mucus production in people with chronic obstructive pulmonary disease (COPD), a new study shows. The researchers note that their findings do not change existing recommendations that people with COPD should…

AERO-007 — a combination of two classes of bronchodilators delivered via a standard jet nebulizer — led to rapid and clinically meaningful improvements in lung function among adults with moderate-to-severe chronic obstructive pulmonary disease (COPD). That’s according to data from the Phase 2a portion of a Phase 1/2a…

One year of treatment with tozorakimab, AstraZeneca’s experimental therapy, was reported to significantly reduce the annual rate of moderate-to-severe exacerbations, or periods of sudden symptom worsening, in adults with chronic obstructive pulmonary disease (COPD). These are the top-line results from the global Phase 3 MIRANDA clinical trial (NCT06040086),…